BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 37981168)

  • 1. The effect of diagnosis delay in testis cancer on tumor size, tumor stage and tumor markers.
    Gercek O; Topal K; Yildiz AK; Ulusoy K; Yazar VM
    Actas Urol Esp (Engl Ed); 2024 Jun; 48(5):356-363. PubMed ID: 37981168
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Human placental alkaline phosphatase (hPLAP) is the most frequently elevated serum marker in testicular cancer].
    Neumann A; Keller T; Jocham D; Doehn C
    Aktuelle Urol; 2011 Sep; 42(5):311-5. PubMed ID: 21809268
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Histologically pure seminoma with elevated alpha-fetoprotein: a clinicopathologic study of ten cases.
    Nazeer T; Ro JY; Amato RJ; Park YW; Ordonez NG; Ayala AG
    Oncol Rep; 1998; 5(6):1425-9. PubMed ID: 9769381
    [TBL] [Abstract][Full Text] [Related]  

  • 4. What Is the Significance of Rete Testis Invasion by Malign Germ Cell Tumor and Does Hilum Predict Metastasis?
    Ediz C; Ihvan A
    Urol Int; 2019; 103(1):49-54. PubMed ID: 31203276
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Surveillance of stage I testicular seminoma: 20 years oncological results].
    Zores T; Mouracade P; Duclos B; Saussine C; Lang H; Jacqmin D
    Prog Urol; 2015 Apr; 25(5):282-7. PubMed ID: 25724863
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum Tumour Markers in Testicular Germ Cell Tumours: Frequencies of Elevated Levels and Extents of Marker Elevation Are Significantly Associated with Clinical Parameters and with Response to Treatment.
    Dieckmann KP; Simonsen-Richter H; Kulejewski M; Anheuser P; Zecha H; Isbarn H; Pichlmeier U
    Biomed Res Int; 2019; 2019():5030349. PubMed ID: 31275973
    [TBL] [Abstract][Full Text] [Related]  

  • 7. When is a Seminoma not a Seminoma? The Incidence, Risk Factors and Management of Patients With Testicular Seminoma With Discordant Elevated Serum Alpha-fetoprotein.
    Fero KE; Lec PM; Sharma V; Lenis AT; Low J; Litwin MS; Leapman MS; Chamie K
    Urology; 2021 Nov; 157():188-196. PubMed ID: 34389428
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The search for biomarkers of metastatic seminoma.
    Ruf CG; Khalili-Harbi N; Sachs S; Isbarn H; Wagner W; Matthies C; Meineke V; Fisch M; Chun FK; Abend M
    J Urol; 2013 Sep; 190(3):1046-51. PubMed ID: 23583226
    [TBL] [Abstract][Full Text] [Related]  

  • 9. May High Levels of Systemic Immune-Inflammation Index and Hematologic Inflammation Markers Suggest a Further Stage in Testicular Tumours?
    Imamoglu GI; Eren T; Baylan B; Karacın C
    Urol Int; 2019; 103(3):303-310. PubMed ID: 31466076
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical characteristics of testicular germ cell tumors in patients aged 50 years and older: A large-scale study from the Cancer Registration Committee of the Japanese Urological Association.
    Kawai T; Tanaka Y;
    Int J Urol; 2017 Feb; 24(2):124-128. PubMed ID: 27915468
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Primary Testicular Neuroendocrine Tumor Coexisting With Seminoma Sharing Germ Cell Origin.
    Iida N; Takemura K; Ito M; Funata N; Yonese I; Suzuki H; Tsuzuki T; Koga F
    Int J Surg Pathol; 2021 Dec; 29(8):887-891. PubMed ID: 33847540
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The incidence, prognosis, clinical and histological characteristics, treatment, and outcome of patients with bilateral germ cell testicular cancer in Hungary.
    Géczi L; Gomez F; Bak M; Bodrogi I
    J Cancer Res Clin Oncol; 2003 May; 129(5):309-15. PubMed ID: 12748851
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Appendix 9: Testicular seminoma and non-seminoma: eUpdate published online 29 June 2017 (www.esmo.org/Guidelines/Genitourinary-Cancers).
    Oldenburg J; Horwich A;
    Ann Oncol; 2017 Jul; 28(suppl_4):iv165-iv166. PubMed ID: 28881930
    [No Abstract]   [Full Text] [Related]  

  • 14. Changing incidence and delay of testicular cancer in southern Norway (1981-1992).
    Hernes EH; Harstad K; Fosså
    Eur Urol; 1996; 30(3):349-57. PubMed ID: 8931969
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunohistochemistry expression of P53, Ki67, CD30, and CD117 and presence of clinical metastasis at diagnosis of testicular seminoma.
    Gallegos I; Valdevenito JP; Miranda R; Fernandez C
    Appl Immunohistochem Mol Morphol; 2011 Mar; 19(2):147-52. PubMed ID: 20881837
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognosis of primary testicular seminoma: a report on 57 new cases.
    Fujikawa K; Matsui Y; Oka H; Fukuzawa S; Sasaki M; Takeuchi H
    Cancer Res; 2000 Apr; 60(8):2152-4. PubMed ID: 10786678
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retroperitoneal Lymph Node Dissection as Primary Treatment for Men With Testicular Seminoma: Utilization and Survival Analysis Using the National Cancer Data Base, 2004-2014.
    Tabakin AL; Shinder BM; Kim S; Rivera-Nunez Z; Polotti CF; Modi PK; Sterling JA; Farber NJ; Radadia KD; Parikh RR; Kim IY; Saraiya B; Mayer TM; Singer EA; Jang TL
    Clin Genitourin Cancer; 2020 Apr; 18(2):e194-e201. PubMed ID: 31818649
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum Levels of MicroRNA-371a-3p (M371 Test) as a New Biomarker of Testicular Germ Cell Tumors: Results of a Prospective Multicentric Study.
    Dieckmann KP; Radtke A; Geczi L; Matthies C; Anheuser P; Eckardt U; Sommer J; Zengerling F; Trenti E; Pichler R; Belz H; Zastrow S; Winter A; Melchior S; Hammel J; Kranz J; Bolten M; Krege S; Haben B; Loidl W; Ruf CG; Heinzelbecker J; Heidenreich A; Cremers JF; Oing C; Hermanns T; Fankhauser CD; Gillessen S; Reichegger H; Cathomas R; Pichler M; Hentrich M; Eredics K; Lorch A; Wülfing C; Peine S; Wosniok W; Bokemeyer C; Belge G
    J Clin Oncol; 2019 Jun; 37(16):1412-1423. PubMed ID: 30875280
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The relationship of neutrophil to lymphocyte ratio with testicular cancer.
    Ilktac A; Dogan B; Ersoz C; Akcay M; Akbulut H
    Int Braz J Urol; 2020; 46(1):101-107. PubMed ID: 31851466
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of the time from the presentation of symptoms to medical consultation on primary tumor size and survival in patients with testicular cancer: Shift in the last 2 decades.
    Kobayashi K; Saito T; Kitamura Y; Nobushita T; Kawasaki T; Hara N; Takahashi K
    Urol Oncol; 2014 Jan; 32(1):43.e17-22. PubMed ID: 23911683
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.